BIT Life Sciences’ 2^nd Annual International Congress of Antibody-2010 (ICA-2010)
Scientific program: March 24-26, 2010
Beijing Continental Grand Hotel, China
( Beijing International Convention Center )

BIT Life Sciences is proud to announce that the 2^nd Annual International Congress of Antibody-2010 (ICA-2010) will be held during March 24-26, 2010 in Beijing, China. ICA-2010 will present topics concerning the very current advancements in antibody research and product development. Discussion areas will focus on the Emerging Antibody Technologies, Antibody Molecular Targets of Cancers,  Targeting Therapeutic Monoclonal Antibody R & D for Major Cancers, Therapeutic MAbs for Various Human Major Diseases, Preclinical /Clinical Studies of Monoclonal Therapeutics, Antibodies for Clinical Diagnostics and Therapy, Antibody Engineering and Production, Bio-Venture on Antibodies.

ICA-2010 will provide a platform for participants to:

Learn the latest technologies and developments for antibodies
Comprehend the best strategies to follow in order to optimally plan antibodies R & D
Gain insights from industry decision makers as they share their thoughts on market trend
Hear opinions from professionals about regulatory issues and policies on antibodies
Build partnerships in China and beyond to catch your targets
Find huge opportunities and markets for your business

On behalf of the organizing committee of ICA-2010, we sincerely hope you could participate and contribute your invaluable experience and knowledge at this important congress.

Beijing is an ancient city with a long history and many precious cultural treasures. This year, Beijing Olympics opening ceremony hailed all over the world and the amazing scene was so impressive on August 8. We believe you will love the dreamy city and our congress when you come to China.

Xiaodan Mei, Ph.D.
Executive Chair
Organizing Committee of ICA Congress